Page results
-
On Sunday 23 November, the Royal National Orthopaedic Hospital (RNOH) successfully connected to UCLH’s Epic electronic health record (EHR). This is another milestone in our collaboration and digital transformation across North Central London.
-
Information on how we ask for your consent to treatment, and Martha's Rule.
-
UCLH has welcomed its 1000th patient to our proton beam therapy department, which opened in December 2021.
-
This page explains what a gastroscopy is and what it involves for patients on a prolonged diet.
-
This page aims to give you information about a way doctors can treat patients who have pancreatic collections or pseudocysts related to pancreatitis (inflammation of the pancreas).
-
Penile plication (Nesbit) procedure post-operative information
-
This service is provided for UCLH patients who are unable to attend hospital appointments by public transport or other means, due to their medical condition.
-
This page explains what a gastroscopy is and what it involves for patients on a standard diet.
-
Information on the insertion of an inflatable penile prosthesis
-
A patient with motor neurone disease was able to control a computer just by using his thoughts following the UK’s first Neuralink implant surgery at UCLH’s National Hospital for Neurology and Neurosurgery (NHNN) in October 2025.
File results
-
FOI/2024/0561 - Gender reassignment and/or transgender policies, mixed/same sex accommodation and Equality Impact Assessments (EIA)
-
FOI/2024/0564 - Transperineal prostate biopsies undertaken in 2023
-
FOI/2024/0568 - Local Anaesthetic Transperineal Prostate (LATP) biopsy service
-
FOI/2024/0570 - Pathway for genetic/ genomic testing for MND
-
FOI/2024/0573 - Treatment for haemophilia A and B/ von Willebrand patients
-
FOI/2024/0575 - Replacement or purchase of patient trolleys in 2024/25
-
FOI/2022/0780 - Hereditary Angioedema (HAE) service
-
FOI/2024/0446 - Skin cancer treatment times 2019/20-2023/24
-
FOI/2024/0458 - Infected blood products, patient numbers 2019/20-2023/24
-
FOI/2024/0577 - Diffuse Large B Cell Lymphoma treatments